AHA, others voice support for drug shortages bill

Mar 05, 2020 - 02:02 PM
house-passes-bill

Reps. Scott Peters, D-Calif., Eliot Engel, D-N.Y., Brett Guthrie, R-KY, Anna Eshoo, D-Calif., Richard Hudson, R-N.C., Michael McCaul, R-Texas, Kurt Schrader, D-Ore., and Gus Bilirakis, D-Fla., yesterday introduced the Preventing Drug Shortages Act (H.R. 6080). 

The AHA-supported bill would strengthen drug shortage reporting requirements under the Food and Drug Administration Safety and Innovation Act of 2012 to include manufacturers of active pharmaceutical ingredients and information such as the cause, extent and expected duration of shortages. It also would require manufacturers to implement risk management plans.

“The Preventing Drug Shortages Act builds upon the prior work of Congress to provide additional authority to the FDA to help mitigate drug shortages to ensure a stable supply of medications critical for patient care,” AHA and other 12 national organizations said in a letter of support for the bill.

Last week, AHA and others urged the Senate Health, Education, Labor and Pensions Committee to quickly advance the Mitigating Emergency Drug Shortages (MEDS) Act (S.2723), bipartisan legislation that also would strengthen drug shortage reporting requirements and include manufacturers of active pharmaceutical ingredients, among other provisions. 
 

Related News Articles

Headline
FDA issues most serious recall for two Smiths Medical infusion pumps
The Food and Drug Administration issued Class I recalls, the most serious type, for two Smiths Medical infusion pumps due to the potential for serious injury…
Headline
AHA makes 100 suggestions to Trump administration on providing regulatory relief 
The AHA May 12 responded to the Office of Management and Budget's April 11 request for information on regulatory relief, making 100 suggestions to the Trump…
Headline
CDC says U.S. at 935 measles cases 
The U.S. has had 935 confirmed cases of measles so far this year, according to the latest data from the Centers for Disease Control and Prevention. Cases have…
Headline
FDA announces recall for certain IV bags
The Food and Drug Administration published a notice from Amneal Pharmaceutical that said the company is recalling two lots of its Ropivacaine Hydrochloride…
Headline
Recall issued for aspiration system by Q’Apel Medical
The Food and Drug Administration has identified a Class I recall of Q’Apel Medical 072 Aspiration System after the company submitted three device event reports…
Headline
Whooping cough cases surpass 8,000 nationwide
There have been 8,064 reported cases of whooping cough in the U.S. so far this year, according to the latest data from the Centers for Disease Control and…